As the Director of
the Early Phase Clinical Trials Program at Roswell Park, I am responsible for developing novel therapies for many types of cancer, including melanoma.
To address the challenges involved in this process, the C2T2 brings together
our early phase clinical trials program, precision cancer medicine initiatives, and non-invasive imaging core.
Chief of Melanoma; Director,
Early Phase Clinical Trials Program; and Co-Leader, CCSG Experimental Therapeutics Program
In my role as a Clinical Professor of Medicine, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Professor of Medicine and Director of
Early Phase Clinical Trials Program in the Department of Medicine at Roswell Park Comprehensive Cancer Center, I am developing novel therapies for patients with cancer.
Not exact matches
Under the new organizational structure, Genentech Research and
Early Development
program, dubbed gRED, which essentially comprises basic research up to
Phase 2
clinical trials, will maintain its autonomy.
A combination of complementary immunotherapy drugs brentuximab vedotin (Adcetris ®) and nivolumab (Opdivo ®) destroyed most cancer cells in 64 percent of patients with recurrent Hodgkin lymphoma, according to the results of an
early -
phase clinical trial led by Catherine M. Diefenbach, MD, assistant professor of medicine and director of the Clinical Lymphoma
clinical trial led by Catherine M. Diefenbach, MD, assistant professor of medicine and director of the
Clinical Lymphoma
Clinical Lymphoma
Program.
The Center for Cancer Targeted Therapies (C2T2) integrates a
phase I - Ib /
early clinical trials program, a precision cancer medicine infrastructure with expertise on tumor tissue - based state - of - the - art molecular methods, and a core resource with novel non-invasive functional imaging methods.
The Brain and Spinal Tumor
Program at the Kimmel Cancer Center is a member of the Adult Brain Tumor Consortium (ABTC), a group of 16 medical centers dedicated to improving treatments for adults with malignant brain tumors by initiating
early phase clinical trials and collaborations with researchers and other
clinical trials groups.